DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/7tvvvl/global_glaucoma) has announced the addition of the “Global Glaucoma Partnering 2010 to 2016” report to their offering. The Global Glaucoma Partnering Terms…
Victor T. Curtin, MD, long-time professor at Bascom Palmer, dies
Victor T. Curtin, MD, professor emeritus of ophthalmology at Bascom Palmer Eye Institute, died March 9 in Miami. Curtin was the first faculty member recruited for Bascom Palmer Eye Institute, University of Miami School of Medicine, where he serve…
iStent reduces IOP with no postop medication through 18 months
FORT LAUDERDALE, Fla. — A second-generation ab interno stent reduced IOP to less than 15 mm Hg without postoperative medication through 18 months in patients with open-angle glaucoma, according to a scientific poster presented here. Richard A. Lewis, MD, reported study results on behalf of the MIGS Study Group at the American Glaucoma Society meeting.
New treatment for common incurable eye condition
MedInsight Research Institute and Ariel University Center for Drug Repurposing present new pterygium/pinguecula treatment results at Israeli Ophthalmology Conference.
Complex learning dismantles barriers in the brain
Biology lessons teach us that the brain is divided into separate areas, each of which processes a specific sense.
Aggressive intervention minimizes sight-threatening potential of periorbital necrotizing fasciitis
PHILADELPHIA — Early identification, immediate and aggressive surgical intervention, and application of both systemic and postoperative topical clindamycin can be sight-saving in cases of periorbital necrotizing fasciitis, according to a presentation here.“Necrotizing fasciitis of the periorbital region is an exceedingly rare condition, with less than 100 cases reported over the past 20 years,” Charles Kim, MD, said at the Wills Eye Alumni Conference “To put it in further perspective, the two largest case series to date consist of 17 and seven patients, respectively, so the span of five, our project, (Read more...)